EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyseOpen Access · CC BY 4.0

Efficacy of fluoroquinolone prophylaxis in high-risk neutropenic patients with haematological malignancies: a systematic review with meta-analysis

Lorenzo Onorato, Margherita Macera, Mariagrazia Palamone, Francesca Ambrisi, Nicola Coppola

Infection · 2026-08 · 54 (4) · 1969-1980

DOI: 10.1007/s15010-026-02824-9 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Infection, online erschienen am 27.05.2026. Verfasst von Lorenzo Onorato und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Mental Health and Public Medicine- Infectious Diseases Unit, Section of Infectious Diseases, University of Campania Luigi Vanvitelli, V…. Hauptthemen laut MEDLINE: Hematologic Neoplasms, Fluoroquinolones, Antibiotic Prophylaxis, Neutropenia. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Università degli Studi della Campania Luigi Vanvitelli.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

To compare the clinical and microbiological outcomes of high-risk neutropenic patients receiving or not fluoroquinolone prophylaxis. Study eligibility criteria Randomized controlled trials (RCTs) and observational studies investigating overall mortality and rate of febrile episodes, of bloodstream infections and of isolation of a fluoroquinolone-resistant strain among patients receiving or not prophylaxis.

Participants

Patients with high-risk neutropenia due to haematological malignancies.

Interventions

Prophylaxis with either ciprofloxacin or levofloxacin. Comparator No prophylaxis. Methods of data synthesis We conducted a meta-analysis pooling risk ratios (RRs) through random effect models.

Results

Among 1731 articles screened, 18 original studies fulfilled the inclusion criteria and were included in the analysis, accounting for a total of 12,586 patients, 7157 (56.9%) of which receiving fluoroquinolones prophylaxis. The analysis assessing the primary outcome including 12,134 patients showed similar mortality rates between groups (RR 1.04, 95% CI 0.79–1.37, p = 0.77), with a low statistical heterogeneity observed (I 2 49.4%, p = 0.022). These findings were confirmed (RR 1.16, 95% CI 0.89–1.50, p = 0.27) in the sub-analysis excluding studies conducted in settings with low prevalence of fluoroquinolone resistance, on a total of 3121 patients, and a low heterogeneity was observed (I 2 27.6%, p = 0.18). Regarding the incidence of febrile episodes, a lower rate was observed among the 1701 patients receiving prophylaxis as compared to the 1514 not receiving prophylaxis (RR 0.87, 95% CI 0.88–0.96, p = 0.006); similarly, a lower rate of bloodstream infections was demonstrated among subjects receiving fluoroquinolone prophylaxis (RR 0.59, 95% CI 0.47–0.75, p < 0.001) in a meta-analysis including 11,681 patients. Finally, no difference in the isolation rate of fluoroquinolone resistant strains was observed (RR 0.87, 95% CI 0.34–2.20, p = 0.77) among 1481 patients included.

Conclusions

Our data suggest that fluoroquinolone prophylaxis in high-risk neutropenic patients is associated with a reduction in the incidence of febrile episodes and bacteraemia but does not provide a survival benefit.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hematologic NeoplasmsFluoroquinolonesAntibiotic ProphylaxisNeutropeniaAnti-Bacterial AgentsHumansBacteremiaTreatment OutcomeDrug Resistance, BacterialRandomized Controlled Trials as Topic

Stichwörter der Autor:innen

Bloodstream infectionsFebrile neutropeniaFluoroquinoloneHaematological malignanciesProphylaxis

Substanzen

FluoroquinolonesAnti-Bacterial Agents

Autor:innen und Institutionen

  • Department of Mental Health and Public Medicine- Infectious Diseases Unit, Section of Infectious Diseases, University of Campania Luigi Vanvitelli, Via L. Armanni 5, 80131, Naples, Italy.
  • Department of Mental Health and Public Medicine- Infectious Diseases Unit, Section of Infectious Diseases, University of Campania Luigi Vanvitelli, Via L. Armanni 5, 80131, Naples, Italy. nicola.coppola@unicampania.it.

Förderung

  • Università degli Studi della Campania Luigi Vanvitelli

Zitieren

APA

Onorato, L., Macera, M., Palamone, M., Ambrisi, F., & Coppola, N. (2026). Efficacy of fluoroquinolone prophylaxis in high-risk neutropenic patients with haematological malignancies: a systematic review with meta-analysis. Infection, 54(4), 1969-1980. https://doi.org/10.1007/s15010-026-02824-9

Vancouver

Onorato L, Macera M, Palamone M, Ambrisi F, Coppola N. Efficacy of fluoroquinolone prophylaxis in high-risk neutropenic patients with haematological malignancies: a systematic review with meta-analysis. Infection. 2026;54(4):1969-1980. doi:10.1007/s15010-026-02824-9

BibTeX
@article{Onorato2026,
  author = {Onorato, Lorenzo and Macera, Margherita and Palamone, Mariagrazia and Ambrisi, Francesca and Coppola, Nicola},
  title = {Efficacy of fluoroquinolone prophylaxis in high-risk neutropenic patients with haematological malignancies: a systematic review with meta-analysis},
  journal = {Infection},
  year = {2026},
  volume = {54},
  number = {4},
  pages = {1969--1980},
  doi = {10.1007/s15010-026-02824-9}
}
Kostenlos starten →